FNC
GILD icon

First National Corp’s Gilead Sciences GILD Stock Holding History

First National Corp’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,016
Closed -$224K – 182
2025
Q2 		$224K Hold
2,016
– – 0.05% 159
2025
Q1 		$226K Buy
+2,016
New +$208K 0.05% 150
2023
Q2 		– Sell
-2,565
Closed -$213K – 160
2023
Q1 		$213K Hold
2,565
– – 0.05% 160
2022
Q4 		$220K Buy
+2,565
New +$203K 0.05% 149

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

First National Corp's GILD Position: Q3 2025 in Review

First National Corp sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 2,016 shares — an estimated $224K sold.

First National Corp first reported a position in GILD in Q4 2022 and held it in 4 quarters. The position peaked at $226K in Q1 2025. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • First National Corp reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • First National Corp sold 2,016 Gilead Sciences shares in Q3 2025, an estimated $224K.
  • First National Corp first reported a position in Gilead Sciences in Q4 2022 and held it in 4 quarters.
  • First National Corp's Gilead Sciences position peaked at $226K in Q1 2025.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on First National Corp's 13F filing for Q3 2025, filed 28 Oct 2025.